Proudfit Christine L, Atta Emad, Doyle Nora M
Department of Gynecology and Obstetrics, and Division of Maternal Fetal Medicine, Emory University School of Medicine, Atlanta, Georgia, USA.
Obstet Gynecol. 2007 Aug;110(2 Pt 2):471-4. doi: 10.1097/01.AOG.0000258784.61584.f5.
Preoperative transfusions are frequently given to prevent morbidity in nonpregnant patients with sickle cell disease. We describe a case of a life-threatening delayed hemolytic transfusion reaction with hyperhemolysis syndrome in pregnancy.
A multigravida with sickle cell disease underwent prophylactic blood transfusion before repeat cesarean delivery. Her immediate postpartum course was uneventful, but on postoperative day number 6 she presented in grave condition with what was thought initially to be an infection versus crisis. Delayed hemolytic transfusion reaction with hyperhemolysis was ultimately diagnosed.
In the gravida with sickle cell disease and known multiple red cell antibodies, blood transfusion may incur a higher risk for delayed transfusion reaction, hyperhemolysis syndrome, and possible death. Blood transfusion should be used cautiously in these patients.
术前输血常用于预防非妊娠镰状细胞病患者的发病情况。我们描述了一例妊娠期发生危及生命的延迟性溶血性输血反应并伴有高溶血综合征的病例。
一名患有镰状细胞病的经产妇在再次剖宫产术前接受了预防性输血。她产后初期情况平稳,但术后第6天病情严重,最初被认为是感染或病情危象。最终诊断为伴有高溶血的延迟性溶血性输血反应。
对于患有镰状细胞病且已知有多种红细胞抗体的孕妇,输血可能会导致更高的延迟性输血反应、高溶血综合征风险以及可能的死亡风险。这些患者应谨慎使用输血。